Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05532670 · ClinicalTrials.gov registry record
N600X Low Saturation Accuracy Validation
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 15
- Enrollment target
NCT05532670 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 15 participants.
The verdict
NCT05532670 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
Study Summary
To compare pulse oximetry saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
Interventions
- DEVICE Non-Invasive Controlled Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-09-29 |
| Est. Completion | 2022-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05532670
The ClinicalTrials.gov registry entry for NCT05532670 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Invasive Controlled Hypoxia is the first listed.
NCT05532670 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05532670 about?
NCT05532670 is a clinical study titled "N600X Low Saturation Accuracy Validation". To compare pulse oximetry saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
What is the current status of trial NCT05532670?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2022-09-29. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT05532670?
The interventions under investigation include: Non-Invasive Controlled Hypoxia (DEVICE).
Who is sponsoring clinical trial NCT05532670?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.